This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, B.
Right arrow Articles by Kastan, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, B.
Right arrow Articles by Kastan, M. B.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, May 2001, p. 3445-3450, Vol. 21, No. 10
0270-7306/01/$04.00+0   DOI: 10.1128/MCB.21.10.3445-3450.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Involvement of Brca1 in S-Phase and G2-Phase Checkpoints after Ionizing Irradiation

Bo Xu, Seong-tae Kim, and Michael B. Kastan*

Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105

Received 16 January 2001/Returned for modification 13 February 2001/Accepted 18 February 2001


    ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Cell cycle arrests in the G1, S, and G2 phases occur in mammalian cells after ionizing irradiation and appear to protect cells from permanent genetic damage and transformation. Though Brca1 clearly participates in cellular responses to ionizing radiation (IR), conflicting conclusions have been drawn about whether Brca1 plays a direct role in cell cycle checkpoints. Normal Nbs1 function is required for the IR-induced S-phase checkpoint, but whether Nbs1 has a definitive role in the G2/M checkpoint has not been established. Here we show that Atm and Brca1 are required for both the S-phase and G2 arrests induced by ionizing irradiation while Nbs1 is required only for the S-phase arrest. We also found that mutation of serine 1423 in Brca1, a target for phosphorylation by Atm, abolished the ability of Brca1 to mediate the G2/M checkpoint but did not affect its S-phase function. These results clarify the checkpoint roles for each of these three gene products, demonstrate that control of cell cycle arrests must now be included among the important functions of Brca1 in cellular responses to DNA damage, and suggest that Atm phosphorylation of Brca1 is required for the G2/M checkpoint.


    INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

The cellular responses to DNA damage induced by ionizing radiation (IR) include activation of cell cycle checkpoints that delay progression of cells through the cell cycle (6, 7). IR-induced checkpoints are active at the transition from the G1 phase to the S phase, in the S phase, and at the transition from the G2 phase to mitosis (G2/M). The surveillance mechanisms responsible for initiating these checkpoints appear to facilitate maintenance of the integrity of the genome, presumably because they ensure that damaged DNA templates are neither replicated nor segregated into the daughter cells until they are repaired. The option to undergo apoptosis can be considered as one of the checkpoint endpoints, and a failure of the cell to die under appropriate circumstances can lead to inappropriate survival of cells with altered genomes. Failure of these mechanisms to adequately monitor the state of DNA or to signal for repair or apoptosis after DNA has been damaged is a hallmark of most cancer cells (7).

The regulatory network of proteins involved in cell cycle checkpoints has been the focus of numerous studies, and the protein Atm plays a central role in this network in mammalian cells (16, 19). The ATM gene is mutated in the autosomal recessive disease ataxia-telangeictasia (A-T). Patients with A-T display a complex phenotype of clinical abnormalities, including progressive cerebellar ataxia, telangiectasias, predisposition to cancer, and hypersensitivity to IR (11). Cells from A-T patients show defects in cell cycle checkpoints and hypersensitivity to IR. Since Atm activity is required for optimal induction and phosphorylation of p53 protein following IR, the G1 checkpoint is affected in A-T cells (3, 9, 23). A lack of an IR-induced S-phase checkpoint results in persistent DNA synthesis at early time points after IR (radioresistant DNA synthesis [RDS]), and cells derived from patients with A-T and Nijmegen breakage syndrome (NBS) exhibit this abnormal phenotype (22). Atm phosphorylation of serine 343 in Nbs1, the altered protein in NBS, has recently been shown to be required for this IR-induced S-phase checkpoint (13, 27). Though additional substrates of Atm kinase have been found, including Brca1, Chk2, CtIP, and Mdm2 (5, 10, 12, 15), Atm phosphorylation of these targets has not been definitively functionally linked to the IR-induced S-phase or G2/M cell cycle checkpoints.

Accumulated data have demonstrated an important role for Brca1 in cellular responses to IR (20); however, conflicting conclusions have been drawn about whether Brca1 plays a direct role in cell cycle checkpoints. Though deletion of exon 11 from Brca1 in primary murine cells affects a G2/M checkpoint and causes mitotic abnormalities (25), normal IR-induced G2/M and S-phase checkpoints have been reported for the Brca1-defective human tumor cell line HCC1937 (21). Similarly, though normal Nbs1 function is clearly required for the IR-induced S-phase checkpoint, a definitive role for Nbs1 in the G2/M checkpoint has not been established. Results reported here demonstrate that Nbs1 is not required for the G2/M checkpoint whereas Brca1 function is required for both the IR-induced S-phase and G2/M checkpoints. Further, Atm phosphorylation of serine 1423 in Brca1 is implicated in the G2/M checkpoint signaling pathway.


    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Cell culture and irradiation. Epstein-Barr virus-immortalized lymphoblastoid cell lines from healthy persons (GM0536; NIGMS Human Mutant Cell Repository, Camden, N.J.) and from persons who were homozygous for the NBS1 mutation (NBS7078A) (4) were cultured in RPMI 1640 supplemented with 15% fetal bovine serum. Simian virus 40-transformed human fibroblast lines from a healthy A-T heterozygote or from a patient with A-T (GM0637 or GM9607, respectively; NIGMS Human Mutant Cell Repository) and the Brca1-mutant human breast cancer cell line HCC1937 and HeLa cells (both from the American Type Culture Collection, Manassas, Va.) were all grown as monolayers in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum. AT22IJET cells, generously provided by Yossi Shiloh (Tel Aviv University), were maintained in 100 µg of hygromycin B (Life Technologies, Rockville, Md.) ml-1. Note that the ATM heterozygous GM0637 cells are indistinguishable from cells with two wild-type ATM alleles in the RDS assay (data not shown). All cell lines were grown at 37°C in a humidified atmosphere containing 5% CO2. Radiation from a 137Cs source was delivered at a rate of approximately 120 cGy/min.

Immunofluorescent detection of phosphorylated histone H3. Cells were harvested 1 to 1.5 h after irradiation, washed with phosphate-buffered saline (PBS), and fixed in suspension (concentration, 106 cells per ml) by the addition of 2 ml of 70% ethanol and by incubation at -20°C for as long as 24 h. After fixation, the cells were washed twice with PBS, suspended in 1 ml of 0.25% Triton X-100 in PBS, and incubated on ice for 15 min. After centrifugation, the cell pellet was suspended in 100 µl of PBS containing 1% bovine serum albumin (BSA) and 0.75 µg of a polyclonal antibody that specifically recognizes the phosphorylated form of histone H3 (Upstate Biotechnology, Lake Placid, N.Y.) and incubated for 3 h at room temperature. The cells were then rinsed with PBS containing 1% BSA and incubated with fluorescein isothiocyanate-conjugated goat anti-rabbit immunoglobulinG antibody (Jackson ImmunoResearch Laboratories, Inc., West Grove, Pa.) diluted at a ratio of 1:30 in PBS containing 1% BSA. After a 30-min incubation at room temperature in the dark, the cells were washed again, resuspended in 25 µg of propidium iodide (PI) (Sigma, St. Louis, Mo.)/ml and 0.1 mg of RNase A (Sigma)/ml in PBS, and incubated at room temperature for 30 min before the fluorescence was measured. Cellular fluorescence was measured by using a Becton Dickinson (San Jose, Calif.) FACSCalibur flow cytometer/cell sorter.

RDS assay. Inhibition of DNA synthesis after irradiation was assessed as previously described (13, 17). Briefly, cells in the logarithmic phase of growth were prelabeled by culturing in DMEM containing 10 nCi of [14C]thymidine (NEN Life Science Products, Inc., Boston, Mass.) for approximately 24 h; this prelabeling provides an internal control for cell number by allowing normalization for total DNA content of samples. The medium containing [14C]thymidine was then replaced with normal DMEM, and the cells were incubated for another 24 h. When cells were to be transiently transfected, they were incubated in normal DMEM for 6 h after the [14C]thymidine-containing medium was discarded. Cells were irradiated, incubated for 30 to 45 min, and then pulse-labeled with 2.5 µCi of [3H]thymidine (NEN Life Science Products)/ml for 15 min. Cells were harvested, washed twice with PBS, and fixed in 70% methanol for at least 30 min. After the cells were transferred to Whatman filters and fixed sequentially with 70% and then 95% methanol, the filters were air dried and the amount of radioactivity was assayed in a liquid scintillation counter. The resulting ratios of 3H counts per minute to 14C counts per minute, corrected for those counts per minute that were the result of channel crossover, were a measure of DNA synthesis.

Transfection of wild-type and mutated BRCA1 genes into HCC1937 cells. Transfection of HCC1937 cells with the gene encoding hemagglutinin-tagged wild-type Brca1 (generously provided by D. Livingston, Dana Farber Cancer Institute, Boston, Mass.) or mutant (alanine substitution at serine 1423) Brca1 and transfection of HeLa cells with kinase-inactive ATM (2, 13) were performed in the logarithmic phase of growth with Lipofectamine (Life Technologies). The efficiency of transfection was assessed by cotransfection with a green fluorescent protein (GFP) reporter vector and analyzing for GFP expression by flow cytometry 36 h after transfection. The efficiency of transfection in multiple assessments was always between 90 and 97% (data not shown). For assessment of Brca1 expression in the transfectants, the cells were harvested 48 h after transfection and total cellular lysates were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis in an 8% polyacrylamide gel. Expressed transfected Brca1 proteins were detected by Western blot analysis with an antihemagglutinin monoclonal antibody (Roche Molecular Biochemicals, Indianapolis, Ind.).


    RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Brca1 participates along with Atm and Nbs1 in the IR-induced S-phase checkpoint. The IR-induced S-phase checkpoint in mammalian cells is thought to primarily represent an inhibition of replicon initiation and is measured as a transient decrease in [3H]thymidine incorporation at early time points (30 to 90 min) after irradiation (18). The absence of this IR-induced S-phase arrest, referred to as a RDS, has been previously reported for cells from both A-T and NBS patients (22). One study has reported a normal S-phase checkpoint in Brca1-null cells (21), but no experimental details or data were provided to support this conclusion. In our hands, the S-phase arrest after irradiation over an IR dose range from 5 to 20 Gy in the Brca1-null cell line HCC1937 was defective and was indistinguishable from cells lacking Atm or Nbs1 (Fig. 1A).


View larger version (18K):
[in this window]
[in a new window]
  		FIG. 1.   Atm, Nbs1, and Brca1 are all involved in the S-phase checkpoint activated by IR. (A) Replicative DNA synthesis was assessed 30 min after various doses of ionizing irradiation in control cells (GM0637) and cells defective in Atm (GM9607), Nbs1 (NBS7078A), or Brca1 (HCC1937) function. (B) Replicative DNA synthesis was assessed 30 min after various doses of ionizing irradiation in control cells (GM0637) and in HCC1937 cells transfected with either empty vector or wild-type BRCA1. Error bars represent the averages of at least triplicate samples. If the error bar is not visible, the standard error is smaller than the symbol.

To demonstrate that this abnormality was due to a lack of Brca1 function and not some other genetic alteration in this cell line, the HCC1937 cells were transfected with a full-length BRCA1 cDNA and the complemented cells were assessed for this checkpoint. Flow cytometric analysis of GFP expression indicated that the transfection efficiency was greater than 90%, and expression of the wild-type Brca1 was easily detected by Western blot analysis. Because transient overexpression of Brca1 can induce apoptosis, the cells were irradiated 36 h after transfection, a time point when wild-type Brca1 was expressed and the number of apoptotic cells was minimized. Brca1 transfection by itself did not affect the [3H]thymidine incorporation in nonirradiated cells. However, the IR-induced S-phase checkpoint was restored in the HCC1937 cells following complementation with Brca1 (Fig. 1B). These results demonstrate that, in addition to the previously reported involvement of Atm and Nbs1, normal Brca1 function is also required for the IR-induced S-phase checkpoint.

Development of a facile assay to evaluate the G2-to-M transition after irradiation in mammalian cells by flow cytometry. Rapid assessment of the progression of cells from G2 into mitosis is made difficult by the fact that both G2 and mitotic cells have a 4N DNA content and thus are not simply distinguishable from each other by standard PI staining and flow cytometry. Historically, the lack of the IR-induced G2 checkpoint in A-T cells has been assessed by performing mitotic spreads and counting the mitotic cells remaining in the culture at various times after IR (17, 26). Using such an assay, the number of mitotic figures is markedly diminished within 30 min after IR in cells from healthy individuals while cells from A-T patients continue to exhibit mitoses. However, this type of assay is both cumbersome to perform and difficult to quantitate accurately. These difficulties could be circumvented by having a facile way to distinguish the G2 cells from the mitotic cells in the population of cells with a 4N DNA content. Since histone H3 is phosphorylated exclusively during mitosis, an antibody that specifically recognizes the phosphorylated form of histone H3 can be used to identify the mitotic cells and thus distinguish G2 cells from mitotic cells in a flow cytometric assay (8). Costaining of cells with PI to assess DNA content and an anti-phospho-histone H3 antibody demonstrates that the mitotic cells can be distinguished from G2 cells in the 4N population of cells (Fig. 2A, top row, first column). Note that we have used this assay in a variety of different mammalian cell types and the 1.5% to 3% of cells in mitosis at any given time has been very reproducible (Fig. 2B and data not shown). Within 30 to 60 min after irradiation, a significant decrease in the number of cells in mitosis was evident (Fig. 2A, top row, second column, and B). The decrease of the mitotic percentage is time dependent and dose independent (data not shown). In normal cells, the number of mitotic cells will drop 80% within an hour (Fig. 2B). These effects after IR are qualitatively the same as those seen when mitotic entry is assessed by counts of mitotic spreads (data not shown), but counts of mitotic figures in such analyses are difficult to accurately quantitate. Thus, this flow cytometric assay provides a facile and quantitative way to assess the IR-induced G2 checkpoint and the genetic determinants that control it.


View larger version (29K):
[in this window]
[in a new window]
  		FIG. 2.   Atm and Brca1, but not Nbs1, are required for the IR-induced G2 checkpoint. (A) Flow cytometric profiles of cell cycle distribution before [IR(-)] and 1 h after [IR(+)] IR using a combination of staining for DNA content (y axis) and for histone H3 phosphorylation (x axis). The 4N population of cells is distinguished as either in G2 or in mitosis (encircled, M). Control cells (GM0536 and HeLa+vector) and cells defective in Nbs1 (NBS7078A) exhibit a marked decrease in the number of mitotic cells after IR, while cells defective in Atm (GM9607 and HeLa+kdATM) or Brca1 (HCC1937) continue to enter mitosis after IR. (B) Mitotic cells as a percentage of total cells before and after IR (quantitation of data shown in panel A). The error bars represent the variability after combining the results of at least three different experiments for each cell line.

Participation of Atm and Brca1, but not Nbs1, in the IR-induced G2 checkpoint. Cells from A-T patients have previously been shown to lack IR-induced G2 arrest (1, 17), and this flow cytometric assay confirmed this abnormality. While irradiation of normal cells (GM0536) resulted in an approximately 75% decrease in the number of mitotic cells, there was little to no decrease in the percentage of A-T cells (GM9607) in mitosis 60 min after irradiation (Fig. 2). This checkpoint abnormality was observed in a large number of different A-T cell lines (data not shown). Inhibition of Atm function in HeLa cells by transfection of a dominant-negative construct of ATM similarly demonstrated the loss of the G2 checkpoint (Fig. 2, HeLa+kdATM). In contrast to the cells with defective Atm function, cells from an NBS patient (NBS7078A) exhibited a normal IR-induced G2 checkpoint (Fig. 2). Thus, in contrast to its critical role in the S-phase checkpoint, Nbs1 function does not appear to be required for the G2 checkpoint. The Brca1-null cell line HCC1937 exhibited a G2/M checkpoint abnormality similar to that seen in the A-T cells (Fig. 2). In order to assess whether this abnormality in HCC1937 cells was due to their altered Brca1 function, wild-type Brca1 was reintroduced into the cells by transient transfection. Transfection of Brca1 did not affect cell cycle distribution in nonirradiated cells. However, restoration of Brca1 function restored the IR-induced G2 arrest in these cells (Fig. 3), thus demonstrating a role for Brca1 in this checkpoint pathway.


View larger version (28K):
[in this window]
[in a new window]
  		FIG. 3.   Introduction of wild-type Brca1 complements the G2/M checkpoint defect in HCC1937 cells. (A) Assessment of the G2/M checkpoint as in Fig. 2A, comparing HCC1937 cells transfected with either control vector or wild-type BRCA1. A-T cells transfected with control vector or complemented with wild-type ATM are shown for comparison. (B) Quantitation of data shown in panel A, averaged over three experiments.

Serine 1423 of Brca1 is important for the IR-induced G2/M checkpoint but not the S-phase checkpoint. Since similar cell cycle checkpoint defects were found in cells defective in Atm and Brca1, and since Brca1 is phosphorylated by Atm in vitro and in vivo (5, 24), we examined the impact of mutating a major Atm phosphorylation site in BRCA1 (serine 1423 to alanine). While the mutated Brca1 still rescued the S-phase checkpoint defect in HCC1937 cells (Fig. 4B), the G2/M checkpoint defect was not complemented (Fig. 4C and D). The failure to complement the G2/M checkpoint is not attributable to a lack of expression of the mutant Brca1, since the S-phase checkpoint was rescued in the same cells (Fig. 4B) and since the mutant Brca1 is expressed at levels similar to those of the wild-type protein (Fig. 4A). These results implicate Atm phosphorylation of serine 1423 of Brca1 in the regulation of the IR-induced G2/M checkpoint.


View larger version (39K):
[in this window]
[in a new window]
  		FIG. 4.   BRCA1 mutated at serine 1423 complements the S-phase checkpoint but not the G2/M checkpoint. (A) Expression of transduced hemagglutinin (HA)-tagged Brca1 (wild type and Brca1 with an alanine substitution at serine 1423) was assessed by immunoblotting with anti-HA antibody. beta -Tubulin levels are shown as a loading control. (B) Replicative DNA synthesis was assessed 30 min after 10 Gy of ionizing irradiation in the complemented HCC1937 cells. Error bars represent the averages of at least triplicate samples. (C) Assessment of the G2/M checkpoint comparing HCC1937 cells complemented with either control vector, wild-type Brca1, or Brca1 with serine 1423 mutated to alanine (S1423A). (D) Quantitation of data shown in panel C, averaged over three experiments.


    DISCUSSION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Exposure of cells to DNA-damaging agents can result in perturbations of cell cycle progression and in cell death. The molecular mechanisms controlling these endpoints has important implications for both cancer causation and tumor responses to cytotoxic therapies. Patients carrying mutations in both alleles of the ATM or NBS1 gene are at high risk for the development of lymphoid malignancies (22), while patients with heterozygous mutations in BRCA1 have a markedly increased risk of developing breast or ovarian cancer (14). Cells defective in the function of any of these three gene products exhibit decreased viability after exposure to ionizing irradiation (21, 22). Atm function is also required for the arrests of cell cycle progression in the G1, S, and G2 phases typically seen after the exposure of the cells to ionizing irradiation (9, 16), and Nbs1 function has been reported to be required for the IR-induced S-phase checkpoint but not for the G1 checkpoint (13, 27). However, conclusions about the role of Nbs1 in the G2 checkpoint and the importance of Brca1 in any of these checkpoints have been left somewhat ambiguous from previous reports.

Here, examination of the cell cycle arrests following IR demonstrated that cells defective in any of these three gene products lack the rapid, but transient, arrest typically seen in the S phase. Similar to the previously reported complementation of the S-phase checkpoint defects in Atm-null and Nbs1-null cells with their respective missing gene products (13, 28), introduction of wild-type BRCA1 into Brca1-null cells restored the IR-induced S-phase checkpoint. This implicates Brca1 in the IR-induced S-phase checkpoint for the first time. Though our data suggest that Atm phosphorylation of serine 1423 of Brca1 is not an important step in the IR-induced S-phase delay, this does not mean that Atm phosphorylation of Brca1 is not important for this checkpoint. Since Atm phosphorylates other sites in Brca1 (5), one or more of these other sites could be important for this function. This could be addressed by mutating each phosphorylation site individually and examining them for a failure to complement RDS.

Using a facile flow cytometric assay that distinguishes G2 cells from mitotic cells, we were also able to confirm that the progression of cells from G2 into mitosis is halted at very early times after irradiation and to demonstrate that this IR-induced cell cycle arrest requires the function of Atm and Brca1 but not Nbs1. This result confirms the earlier suggestion from studies with mouse cells (25) that Brca1 participates in the IR-induced G2/M checkpoint. Finally, since mutation of serine 1423 in Brca1, a major phosphorylation site by Atm (5, 24), abolished complementation of the G2/M checkpoint, Atm phosphorylation of this site is implicated in the G2/M checkpoint pathway. This is the first target of Atm that has been shown to affect this checkpoint. Though the mechanism by which Brca1 affects cell cycle progression in G2 remains to be elucidated, the potential involvement of serine 1423 phosphorylation in this process provides a starting point for subsequent investigations.


    ACKNOWLEDGMENTS

We gratefully acknowledge the technical assistance of Jim Houston, Angela Justman, and Diane Woods. We thank all members of the Kastan laboratory for helpful discussions, Yossi Shiloh for providing complemented A-T cells, and David Livingston for providing the wild-type BRCA1 cDNA.

This work was supported by grants from the National Institutes of Health (CA71387 and CA21765) and by the American Lebanese Syrian Associated Charities of the St. Jude Children's Research Hospital.


    FOOTNOTES

* Corresponding author. Mailing address: Department of Hematology-Oncology, St. Jude Children's Research Hospital, 332 N. Lauderdale St., Memphis, TN 38105. Phone: (901) 495-3968. Fax: (901) 495-3966. E-mail: Michael.Kastan{at}stjude.org.


    REFERENCES
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

1. Beamish, H., R. Williams, P. Chen, and M. F. Lavin. 1996. Defect in multiple cell cycle checkpoints in ataxia-telangiectasia postirradiation. J. Biol. Chem. 271:20486-20493[Abstract/Free Full Text].
2. Canman, C. E., D. S. Lim, K. A. Cimprich, Y. Taya, K. Tamai, K. Sakaguchi, E. Appella, M. B. Kastan, and J. D. Siliciano. 1998. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281:1677-1679[Abstract/Free Full Text].
3. Canman, C. E., A. C. Wolff, C. Y. Chen, A. J. Fornace, Jr., and M. B. Kastan. 1994. The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia. Cancer Res. 54:5054-5058[Abstract/Free Full Text].
4. Carney, J. P., R. S. Maser, H. Olivares, E. M. Davis, M. Le Beau, J. R. Yates, III, L. Hays, W. F. Morgan, and J. H. Petrini. 1998. The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell 93:477-486[CrossRef][Medline].
5. Cortez, D., Y. Wang, J. Qin, and S. J. Elledge. 1999. Requirement of ATM-dependent phosphorylation of Brca1 in the DNA damage response to double-strand breaks. Science 286:1162-1166[Abstract/Free Full Text].
6. Elledge, S. J. 1996. Cell cycle checkpoints: preventing an identity crisis. Science 274:1664-1672[Abstract/Free Full Text].
7. Hartwell, L. H., and M. B. Kastan. 1994. Cell cycle control and cancer. Science 266:1821-1828[Abstract/Free Full Text].
8. Juan, G., F. Traganos, W. James, J. Ray, M. Roberge, D. Sauve, H. Anderson, and Z. Darzynkiewicz. 1998. Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis. Cytometry 32:71-77[CrossRef][Medline].
9. Kastan, M. B., Q. Zhan, W. S. el-Deiry, F. Carrier, T. Jacks, W. V. Walsh, B. S. Plunkett, B. Vogelstein, and A. J. Fornace, Jr. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71:587-597[CrossRef][Medline].
10. Khosravi, R., R. Maya, T. Gottlieb, M. Oren, Y. Shiloh, and D. Shkedy. 1999. Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. Proc. Natl. Acad. Sci. USA 96:14973-14977[Abstract/Free Full Text].
11. Lavin, M. F., and Y. Shiloh. 1997. The genetic defect in ataxia-telangiectasia. Annu. Rev. Immunol. 15:177-202[CrossRef][Medline].
12. Li, S., N. Y. Y. Ting, L. Zheng, P.-L. Chen, Y. Ziv, Y. Shiloh, E. Y.-H. Lee, and W.-H. Lee. 2000. Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage responses. Nature 406:210-215[CrossRef][Medline].
13. Lim, D. S., S. T. Kim, B. Xu, R. S. Maser, J. Lin, J. H. Petrini, and M. B. Kastan. 2000. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature 404:613-617[CrossRef][Medline].
14. Martin, A., and B. Weber. 2000. Genetic and hormonal risk factors in breast cancer. J. Natl. Cancer Inst. 92:1126-1135[Abstract/Free Full Text].
15. Matsuoka, S., G. Rotman, A. Ogawa, Y. Shiloh, K. Tamai, and S. Elledge. 2000. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc. Natl. Acad. Sci. USA 97:10389-10394[Abstract/Free Full Text].
16. Morgan, S. E., and M. B. Kastan. 1997. p53 and ATM: cell cycle, cell death, and cancer. Adv. Cancer Res. 71:1-25[Medline].
17. Morgan, S. E., C. Lovly, T. K. Pandita, Y. Shiloh, and M. B. Kastan. 1997. Fragments of ATM which have dominant-negative or complementing activity. Mol. Cell. Biol. 17:2020-2029[Abstract].
18. Painter, R. B., and B. R. Young. 1980. Radiosensitivity in ataxia-telangiectasia: a new explanation. Proc. Natl. Acad. Sci. USA 77:7315-7317[Abstract/Free Full Text].
19. Rotman, G., and Y. Shiloh. 1999. ATM: a mediator of multiple responses to genotoxic stress. Oncogene 18:6135-6144[CrossRef][Medline].
20. Scully, R., and D. Livingston. 2000. In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408:429-432[CrossRef][Medline].
21. Scully, R., G. Shridar, K. Vlasakova, J. Chen, M. Socolovsky, and D. Livingston. 1999. Genetic analysis of BRCA1 function in a defined tumor cell line. Mol. Cell 4:1093-1099[CrossRef][Medline].
22. Shiloh, Y. 1997. Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart. Annu. Rev. Genet. 31:635-662[CrossRef][Medline].
23. Siliciano, J. D., C. E. Canman, Y. Taya, K. Sakaguchi, E. Appella, and M. B. Kastan. 1997. DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev. 11:3471-3481[Abstract/Free Full Text].
24. Tibbetts, R., D. Cortez, K. Brumbaugh, R. Scully, D. Livingston, S. Elledge, and R. Abraham. 2000. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev. 14:2989-3002[Abstract/Free Full Text].
25. Xu, X., Z. Weaver, S. P. Linke, C. Li, J. Gotay, X. W. Wang, C. C. Harris, T. Ried, and C. X. Deng. 1999. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol. Cell 3:389-395[CrossRef][Medline].
26. Zampetti-Bosseler, F., and D. Scott. 1981. Cell death, chromosome damage and mitotic delay in normal human, ataxia telangiectasia and retinoblastoma fibroblasts after X-irradiation. Int. J. Radiat. Biol. 39:547-558[CrossRef].
27. Zhao, S., Y. C. Weng, S. S. Yuan, Y. T. Lin, H. C. Hsu, S. C. Lin, E. Gerbino, M. H. Song, M. Z. Zdzienicka, R. A. Gatti, J. W. Shay, Y. Ziv, Y. Shiloh, and E. Y. Lee. 2000. Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products. Nature 405:473-477[CrossRef][Medline].
28. Ziv, Y., A. Bar-Shira, I. Pecker, P. Russell, T. J. Jorgensen, I. Tsarfati, and Y. Shiloh. 1997. Recombinant ATM protein complements the cellular A-T phenotype. Oncogene 15:159-167[CrossRef][Medline].

Molecular and Cellular Biology, May 2001, p. 3445-3450, Vol. 21, No. 10
0270-7306/01/$04.00+0   DOI: 10.1128/MCB.21.10.3445-3450.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • McCord, A. M., Jamal, M., Williams, E. S., Camphausen, K., Tofilon, P. J. (2009). CD133+ Glioblastoma Stem-like Cells are Radiosensitive with a Defective DNA Damage Response Compared with Established Cell Lines. Clin. Cancer Res. 15: 5145-5153 [Abstract] [Full Text]  
  • Shao, G., Patterson-Fortin, J., Messick, T. E., Feng, D., Shanbhag, N., Wang, Y., Greenberg, R. A. (2009). MERIT40 controls BRCA1-Rap80 complex integrity and recruitment to DNA double-strand breaks. Genes Dev. 23: 740-754 [Abstract] [Full Text]  
  • Wu, J., Huen, M. S. Y., Lu, L.-Y., Ye, L., Dou, Y., Ljungman, M., Chen, J., Yu, X. (2009). Histone Ubiquitination Associates with BRCA1-Dependent DNA Damage Response. Mol. Cell. Biol. 29: 849-860 [Abstract] [Full Text]  
  • Parsels, L. A., Morgan, M. A., Tanska, D. M., Parsels, J. D., Palmer, B. D., Booth, R. J., Denny, W. A., Canman, C. E., Kraker, A. J., Lawrence, T. S., Maybaum, J. (2009). Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cells. Molecular Cancer Therapeutics 8: 45-54 [Abstract] [Full Text]  
  • Cheng, W.-H., Muftic, D., Muftuoglu, M., Dawut, L., Morris, C., Helleday, T., Shiloh, Y., Bohr, V. A. (2008). WRN Is Required for ATM Activation and the S-Phase Checkpoint in Response to Interstrand Cross-Link-Induced DNA Double-Strand Breaks. Mol. Biol. Cell 19: 3923-3933 [Abstract] [Full Text]  
  • Weberpals, J. I., Clark-Knowles, K. V., Vanderhyden, B. C. (2008). Sporadic Epithelial Ovarian Cancer: Clinical Relevance of BRCA1 Inhibition in the DNA Damage and Repair Pathway. JCO 26: 3259-3267 [Abstract] [Full Text]  
  • Yan, Y., Black, C. P., Cao, P. T., Haferbier, J. L., Kolb, R. H., Spieker, R. S., Ristow, A. M., Cowan, K. H. (2008). {gamma}-Irradiation-Induced DNA Damage Checkpoint Activation Involves Feedback Regulation between Extracellular Signal-Regulated Kinase 1/2 and BRCA1. Cancer Res. 68: 5113-5121 [Abstract] [Full Text]  
  • Tang, X., Hui, Z.-g., Cui, X.-l., Garg, R., Kastan, M. B., Xu, B. (2008). A Novel ATM-Dependent Pathway Regulates Protein Phosphatase 1 in Response to DNA Damage. Mol. Cell. Biol. 28: 2559-2566 [Abstract] [Full Text]  
  • Martin, R. W., Orelli, B. J., Yamazoe, M., Minn, A. J., Takeda, S., Bishop, D. K. (2007). RAD51 Up-regulation Bypasses BRCA1 Function and Is a Common Feature of BRCA1-Deficient Breast Tumors. Cancer Res. 67: 9658-9665 [Abstract] [Full Text]  
  • Camphausen, K., Tofilon, P. J. (2007). Inhibition of Hsp90: A Multitarget Approach to Radiosensitization. Clin. Cancer Res. 13: 4326-4330 [Abstract] [Full Text]  
  • Xing, J., Spitz, M. R., Lu, C., Zhao, H., Yang, H., Wang, W., Stewart, D. J., Wu, X. (2007). Deficient G2-M and S Checkpoints are Associated with Increased Lung Cancer Risk: A Case-Control Analysis. Cancer Epidemiol. Biomarkers Prev. 16: 1517-1522 [Abstract] [Full Text]  
  • Kim, H., Chen, J., Yu, X. (2007). Ubiquitin-Binding Protein RAP80 Mediates BRCA1-Dependent DNA Damage Response. Science 316: 1202-1205 [Abstract] [Full Text]  
  • Peron, S., Pan-Hammarstrom, Q., Imai, K., Du, L., Taubenheim, N., Sanal, O., Marodi, L., Bergelin-Besancon, A., Benkerrou, M., de Villartay, J.-P., Fischer, A., Revy, P., Durandy, A. (2007). A primary immunodeficiency characterized by defective immunoglobulin class switch recombination and impaired DNA repair. JEM 204: 1207-1216 [Abstract] [Full Text]  
  • Wang, X., Kennedy, R. D., Ray, K., Stuckert, P., Ellenberger, T., D'Andrea, A. D. (2007). Chk1-Mediated Phosphorylation of FANCE Is Required for the Fanconi Anemia/BRCA Pathway. Mol. Cell. Biol. 27: 3098-3108 [Abstract] [Full Text]  
  • Bansal, P., Lazo, J. S. (2007). Induction of Cdc25B Regulates Cell Cycle Resumption after Genotoxic Stress. Cancer Res. 67: 3356-3363 [Abstract] [Full Text]  
  • Heffernan, T. P., Unsal-Kacmaz, K., Heinloth, A. N., Simpson, D. A., Paules, R. S., Sancar, A., Cordeiro-Stone, M., Kaufmann, W. K. (2007). Cdc7-Dbf4 and the Human S Checkpoint Response to UVC. J. Biol. Chem. 282: 9458-9468 [Abstract] [Full Text]  
  • DelloRusso, C., Welcsh, P. L., Wang, W., Garcia, R. L., King, M.-C., Swisher, E. M. (2007). Functional Characterization of a Novel BRCA1-Null Ovarian Cancer Cell Line in Response to Ionizing Radiation. Mol Cancer Res 5: 35-45 [Abstract] [Full Text]  
  • Kaufmann, W. K., Filatov, L., Oglesbee, S. E., Simpson, D. A., Lotano, M. A., McKeen, H. D., Sawyer, L. R., Moore, D. T., Millikan, R. C., Cordeiro-Stone, M., Carey, L. A. (2006). Radiation clastogenesis and cell cycle checkpoint function as functional markers of breast cancer risk. Carcinogenesis 27: 2519-2527 [Abstract] [Full Text]  
  • Gastwirt, R. F., Slavin, D. A., McAndrew, C. W., Donoghue, D. J. (2006). Spy1 Expression Prevents Normal Cellular Responses to DNA Damage: INHIBITION OF APOPTOSIS AND CHECKPOINT ACTIVATION. J. Biol. Chem. 281: 35425-35435 [Abstract] [Full Text]  
  • Mirzoeva, O. K., Kawaguchi, T., Pieper, R. O. (2006). The Mre11/Rad50/Nbs1 complex interacts with the mismatch repair system and contributes to temozolomide-induced G2 arrest and cytotoxicity.. Molecular Cancer Therapeutics 5: 2757-2766 [Abstract] [Full Text]  
  • Robles, A. I., Wright, M. H., Gandhi, B., Feis, S. S., Hanigan, C. L., Wiestner, A., Varticovski, L. (2006). Schedule-Dependent Synergy between the Heat Shock Protein 90 Inhibitor 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin and Doxorubicin Restores Apoptosis to p53-Mutant Lymphoma Cell Lines.. Clin. Cancer Res. 12: 6547-6556 [Abstract] [Full Text]  
  • Dote, H., Burgan, W. E., Camphausen, K., Tofilon, P. J. (2006). Inhibition of hsp90 compromises the DNA damage response to radiation.. Cancer Res. 66: 9211-9220 [Abstract] [Full Text]  
  • Muraoka-Cook, R. S., Caskey, L. S., Sandahl, M. A., Hunter, D. M., Husted, C., Strunk, K. E., Sartor, C. I., Rearick, W. A. Jr., McCall, W., Sgagias, M. K., Cowan, K. H., Earp, H. S. III (2006). Heregulin-Dependent Delay in Mitotic Progression Requires HER4 and BRCA1.. Mol. Cell. Biol. 26: 6412-6424 [Abstract] [Full Text]  
  • Ho, G. P. H., Margossian, S., Taniguchi, T., D'Andrea, A. D. (2006). Phosphorylation of FANCD2 on Two Novel Sites Is Required for Mitomycin C Resistance.. Mol. Cell. Biol. 26: 7005-7015 [Abstract] [Full Text]  
  • Kitao, H., Yamamoto, K., Matsushita, N., Ohzeki, M., Ishiai, M., Takata, M. (2006). Functional Interplay between BRCA2/FancD1 and FancC in DNA Repair. J. Biol. Chem. 281: 21312-21320 [Abstract] [Full Text]  
  • Du, Y.-C., Gu, S., Zhou, J., Wang, T., Cai, H., MacInnes, M. A., Bradbury, E. M., Chen, X. (2006). The Dynamic Alterations of H2AX Complex during DNA Repair Detected by a Proteomic Approach Reveal the Critical Roles of Ca2+/Calmodulin in the Ionizing Radiation-induced Cell Cycle Arrest. Mol. Cell. Proteomics 5: 1033-1044 [Abstract] [Full Text]  
  • Yarden, R. I., Papa, M. Z. (2006). BRCA1 at the crossroad of multiple cellular pathways: approaches for therapeutic interventions.. Molecular Cancer Therapeutics 5: 1396-1404 [Abstract] [Full Text]  
  • Schlegel, B. P., Jodelka, F. M., Nunez, R. (2006). BRCA1 Promotes Induction of ssDNA by Ionizing Radiation.. Cancer Res. 66: 5181-5189 [Abstract] [Full Text]  
  • Deng, C.-X. (2006). BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res 34: 1416-1426 [Abstract] [Full Text]  
  • Hockings, J. K., Thorne, P. A., Kemp, M. Q., Morgan, S. S., Selmin, O., Romagnolo, D. F. (2006). The Ligand Status of the Aromatic Hydrocarbon Receptor Modulates Transcriptional Activation of BRCA-1 Promoter by Estrogen. Cancer Res. 66: 2224-2232 [Abstract] [Full Text]  
  • Greenberg, R. A., Sobhian, B., Pathania, S., Cantor, S. B., Nakatani, Y., Livingston, D. M. (2006). Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes. Genes Dev. 20: 34-46 [Abstract] [Full Text]  
  • Schwartz, G. K., Shah, M. A. (2005). Targeting the Cell Cycle: A New Approach to Cancer Therapy. JCO 23: 9408-9421 [Abstract] [Full Text]  
  • Kennedy, R. D., Gorski, J. J., Quinn, J. E., Stewart, G. E., James, C. R., Moore, S., Mulligan, K., Emberley, E. D., Lioe, T. F., Morrison, P. J., Mullan, P. B., Reid, G., Johnston, P. G., Watson, P. H., Harkin, D. P. (2005). BRCA1 and c-Myc Associate to Transcriptionally Repress Psoriasin, a DNA Damage-Inducible Gene. Cancer Res. 65: 10265-10272 [Abstract] [Full Text]  
  • Schwartz, M., Zlotorynski, E., Goldberg, M., Ozeri, E., Rahat, A., Sage, C. l., Chen, B. P.C., Chen, D. J., Agami, R., Kerem, B. (2005). Homologous recombination and nonhomologous end-joining repair pathways regulate fragile site stability. Genes Dev. 19: 2715-2726 [Abstract] [Full Text]  
  • Lin, S.-Y., Rai, R., Li, K., Xu, Z.-X., Elledge, S. J. (2005). BRIT1/MCPH1 is a DNA damage responsive protein that regulates the Brca1-Chk1 pathway, implicating checkpoint dysfunction in microcephaly. Proc. Natl. Acad. Sci. USA 102: 15105-15109 [Abstract] [Full Text]  
  • Zhang, J., Powell, S. N. (2005). The Role of the BRCA1 Tumor Suppressor in DNA Double-Strand Break Repair. Mol Cancer Res 3: 531-539 [Abstract] [Full Text]  
  • Morgan, M. A., Parsels, L. A., Parsels, J. D., Mesiwala, A. K., Maybaum, J., Lawrence, T. S. (2005). Role of Checkpoint Kinase 1 in Preventing Premature Mitosis in Response to Gemcitabine. Cancer Res. 65: 6835-6842 [Abstract] [Full Text]  
  • Liu, X., Guo, Y., Li, Y., Jiang, Y., Chubb, S., Azuma, A., Huang, P., Matsuda, A., Hittelman, W., Plunkett, W. (2005). Molecular Basis for G2 Arrest Induced by 2'-C-Cyano-2'-Deoxy-1-{beta}-D-Arabino-Pentofuranosylcytosine and Consequences of Checkpoint Abrogation. Cancer Res. 65: 6874-6881 [Abstract] [Full Text]  
  • Choudhury, A. D., Xu, H., Modi, A. P., Zhang, W., Ludwig, T., Baer, R. (2005). Hyperphosphorylation of the BARD1 Tumor Suppressor in Mitotic Cells. J. Biol. Chem. 280: 24669-24679 [Abstract] [Full Text]  
  • Dote, H., Cerna, D., Burgan, W. E., Carter, D. J., Cerra, M. A., Hollingshead, M. G., Camphausen, K., Tofilon, P. J. (2005). Enhancement of In vitro and In vivo Tumor Cell Radiosensitivity by the DNA Methylation Inhibitor Zebularine. Clin. Cancer Res. 11: 4571-4579 [Abstract] [Full Text]  
  • Ferguson, A. M., White, L. S., Donovan, P. J., Piwnica-Worms, H. (2005). Normal Cell Cycle and Checkpoint Responses in Mice and Cells Lacking Cdc25B and Cdc25C Protein Phosphatases. Mol. Cell. Biol. 25: 2853-2860 [Abstract] [Full Text]  
  • Xu, J., Fan, S., Rosen, E. M. (2005). Regulation of the Estrogen-Inducible Gene Expression Profile by the Breast Cancer Susceptibility Gene BRCA1. Endocrinology 146: 2031-2047 [Abstract] [Full Text]  
  • Hickson, I., Zhao, Y., Richardson, C. J., Green, S. J., Martin, N. M. B., Orr, A. I., Reaper, P. M., Jackson, S. P., Curtin, N. J., Smith, G. C. M. (2004). Identification and Characterization of a Novel and Specific Inhibitor of the Ataxia-Telangiectasia Mutated Kinase ATM. Cancer Res. 64: 9152-9159 [Abstract] [Full Text]  
  • Bull, E. E. A., Dote, H., Brady, K. J., Burgan, W. E., Carter, D. J., Cerra, M. A., Oswald, K. A., Hollingshead, M. G., Camphausen, K., Tofilon, P. J. (2004). Enhanced Tumor Cell Radiosensitivity and Abrogation of G2 and S Phase Arrest by the Hsp90 Inhibitor 17-(Dimethylaminoethylamino)-17-demethoxygeldanamycin. Clin. Cancer Res. 10: 8077-8084 [Abstract] [Full Text]  
  • Kennedy, R. D., Quinn, J. E., Mullan, P. B., Johnston, P. G., Harkin, D. P. (2004). The Role of BRCA1 in the Cellular Response to Chemotherapy. JNCI J Natl Cancer Inst 96: 1659-1668 [Abstract] [Full Text]  
  • Tosti, E., Waldbaum, L., Warshaw, G., Gross, E. A., Ruggieri, R. (2004). The Stress Kinase MRK Contributes to Regulation of DNA Damage Checkpoints through a p38{gamma}-independent Pathway. J. Biol. Chem. 279: 47652-47660 [Abstract] [Full Text]  
  • Yu, X., Chen, J. (2004). DNA Damage-Induced Cell Cycle Checkpoint Control Requires CtIP, a Phosphorylation-Dependent Binding Partner of BRCA1 C-Terminal Domains. Mol. Cell. Biol. 24: 9478-9486 [Abstract] [Full Text]  
  • Kim, S. S., Cao, L., Li, C., Xu, X., Huber, L. J., Chodosh, L. A., Deng, C.-X. (2004). Uterus Hyperplasia and Increased Carcinogen-Induced Tumorigenesis in Mice Carrying a Targeted Mutation of the Chk2 Phosphorylation Site in Brca1. Mol. Cell. Biol. 24: 9498-9507 [Abstract] [Full Text]  
  • Wang, J., Wiltshire, T., Wang, Y., Mikell, C., Burks, J., Cunningham, C., Van Laar, E. S., Waters, S. J., Reed, E., Wang, W. (2004). ATM-dependent CHK2 Activation Induced by Anticancer Agent, Irofulven. J. Biol. Chem. 279: 39584-39592 [Abstract] [Full Text]  
  • Parsels, L. A., Parsels, J. D., Tai, D. C.-H., Coughlin, D. J., Maybaum, J. (2004). 5-Fluoro-2'-Deoxyuridine-Induced cdc25A Accumulation Correlates with Premature Mitotic Entry and Clonogenic Death in Human Colon Cancer Cells. Cancer Res. 64: 6588-6594 [Abstract] [Full Text]  
  • Geller, J. I., Szekely-Szucs, K., Petak, I., Doyle, B., Houghton, J. A. (2004). P21Cip1 Is a Critical Mediator of the Cytotoxic Action of Thymidylate Synthase Inhibitors in Colorectal Carcinoma Cells. Cancer Res. 64: 6296-6303 [Abstract] [Full Text]  
  • Silverman, J., Takai, H., Buonomo, S. B.C., Eisenhaber, F., de Lange, T. (2004). Human Rif1, ortholog of a yeast telomeric protein, is regulated by ATM and 53BP1 and functions in the S-phase checkpoint. Genes Dev. 18: 2108-2119 [Abstract] [Full Text]  
  • Zhu, W., Chen, Y., Dutta, A. (2004). Rereplication by Depletion of Geminin Is Seen Regardless of p53 Status and Activates a G2/M Checkpoint. Mol. Cell. Biol. 24: 7140-7150 [Abstract] [Full Text]  
  • Xu, X., Lee, J., Stern, D. F. (2004). Microcephalin Is a DNA Damage Response Protein Involved in Regulation of CHK1 and BRCA1. J. Biol. Chem. 279: 34091-34094 [Abstract] [Full Text]  
  • Choudhury, A. D., Xu, H., Baer, R. (2004). Ubiquitination and Proteasomal Degradation of the BRCA1 Tumor Suppressor Is Regulated during Cell Cycle Progression. J. Biol. Chem. 279: 33909-33918 [Abstract] [Full Text]  
  • Arlt, M. F., Xu, B., Durkin, S. G., Casper, A. M., Kastan, M. B., Glover, T. W. (2004). BRCA1 Is Required for Common-Fragile-Site Stability via Its G2/M Checkpoint Function. Mol. Cell. Biol. 24: 6701-6709 [Abstract] [Full Text]  
  • Wang, W., Nahta, R., Huper, G., Marks, J. R. (2004). TAFII70 Isoform-Specific Growth Suppression Correlates With Its Ability to Complex With the GADD45a Protein. Mol Cancer Res 2: 442-452 [Abstract] [Full Text]  
  • Meek, S. E. M., Lane, W. S., Piwnica-Worms, H. (2004). Comprehensive Proteomic Analysis of Interphase and Mitotic 14-3-3-binding Proteins. J. Biol. Chem. 279: 32046-32054 [Abstract] [Full Text]  
  • Feng, Z., Kachnic, L., Zhang, J., Powell, S. N., Xia, F. (2004). DNA Damage Induces p53-dependent BRCA1 Nuclear Export. J. Biol. Chem. 279: 28574-28584 [Abstract] [Full Text]  
  • Gilmore, P. M., McCabe, N., Quinn, J. E., Kennedy, R. D., Gorski, J. J., Andrews, H. N., McWilliams, S., Carty, M., Mullan, P. B., Duprex, W. P., Liu, E. T., Johnston, P. G., Harkin, D. P. (2004). BRCA1 Interacts with and Is Required for Paclitaxel-Induced Activation of Mitogen-Activated Protein Kinase Kinase Kinase 3. Cancer Res. 64: 4148-4154 [Abstract] [Full Text]  
  • Kitagawa, R., Bakkenist, C. J., McKinnon, P. J., Kastan, M. B. (2004). Phosphorylation of SMC1 is a critical downstream event in the ATM-NBS1-BRCA1 pathway. Genes Dev. 18: 1423-1438 [Abstract] [Full Text]  
  • Garg, R., Geng, C.-D., Miller, J. L., Callens, S., Tang, X., Appel, B., Xu, B. (2004). Molecular Cloning and Characterization of the Catalytic Domain of Zebrafish Homologue of the Ataxia-Telangiectasia Mutated Gene. Mol Cancer Res 2: 348-353 [Abstract] [Full Text]  
  • Garg, R., Callens, S., Lim, D.-S., Canman, C. E., Kastan, M. B., Xu, B. (2004). Chromatin Association of Rad17 Is Required for an Ataxia Telangiectasia and Rad-Related Kinase-Mediated S-Phase Checkpoint in Response to Low-Dose Ultraviolet Radiation. Mol Cancer Res 2: 362-369 [Abstract] [Full Text]  
  • Stojic, L., Mojas, N., Cejka, P., di Pietro, M., Ferrari, S., Marra, G., Jiricny, J. (2004). Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase. Genes Dev. 18: 1331-1344 [Abstract] [Full Text]  
  • Melixetian, M., Ballabeni, A., Masiero, L., Gasparini, P., Zamponi, R., Bartek, J., Lukas, J., Helin, K. (2004). Loss of Geminin induces rereplication in the presence of functional p53. JCB 165: 473-482 [Abstract] [Full Text]  
  • Ouchi, M., Fujiuchi, N., Sasai, K., Katayama, H., Minamishima, Y. A., Ongusaha, P. P., Deng, C., Sen, S., Lee, S. W., Ouchi, T. (2004). BRCA1 Phosphorylation by Aurora-A in the Regulation of G2 to M Transition. J. Biol. Chem. 279: 19643-19648 [Abstract] [Full Text]  
  • Lin, S.-Y., Li, K., Stewart, G. S., Elledge, S. J. (2004). Human Claspin works with BRCA1 to both positively and negatively regulate cell proliferation. Proc. Natl. Acad. Sci. USA 101: 6484-6489 [Abstract] [Full Text]  
  • Camphausen, K., Brady, K. J., Burgan, W. E., Cerra, M. A., Russell, J. S., Bull, E. E.A., Tofilon, P. J. (2004). Flavopiridol enhances human tumor cell radiosensitivity and prolongs expression of {gamma}H2AX foci. Molecular Cancer Therapeutics 3: 409-416 [Abstract] [Full Text]  
  • Kastan, M. B., Kitagawa, R., Bakkenist, C. J. (2004). Signaling to and from ATM after DNA damage.. aacrmtg 2004: 1318-1318 [Abstract]  
  • Tan, W., Zheng, L., Lee, W.-H., Boyer, T. G. (2004). Functional Dissection of Transcription Factor ZBRK1 Reveals Zinc Fingers with Dual Roles in DNA-binding and BRCA1-dependent Transcriptional Repression. J. Biol. Chem. 279: 6576-6587 [Abstract] [Full Text]  
  • Wang, X., Guan, J., Hu, B., Weiss, R. S., Iliakis, G., Wang, Y. (2004). Involvement of Hus1 in the chain elongation step of DNA replication after exposure to camptothecin or ionizing radiation. Nucleic Acids Res 32: 767-775 [Abstract] [Full Text]  
  • Zhang, J., Willers, H., Feng, Z., Ghosh, J. C., Kim, S., Weaver, D. T., Chung, J. H., Powell, S. N., Xia, F. (2004). Chk2 Phosphorylation of BRCA1 Regulates DNA Double-Strand Break Repair. Mol. Cell. Biol. 24: 708-718 [Abstract] [Full Text]  
  • Chen, M.-S., Ryan, C. E., Piwnica-Worms, H. (2003). Chk1 Kinase Negatively Regulates Mitotic Function of Cdc25A Phosphatase through 14-3-3 Binding. Mol. Cell. Biol. 23: 7488-7497 [Abstract] [Full Text]  
  • Yu, X., Chini, C. C. S., He, M., Mer, G., Chen, J. (2003). The BRCT Domain Is a Phospho-Protein Binding Domain. Science 302: 639-642 [Abstract] [Full Text]  
  • Quinn, J. E., Kennedy, R. D., Mullan, P. B., Gilmore, P. M., Carty, M., Johnston, P. G., Harkin, D. P., Benatti, U., Boffa, L. C., Ferrarini, M. (2003). BRCA1 Functions as a Differential Modulator of Chemotherapy-induced Apoptosis. Cancer Res. 63: 6221-6228 [Abstract] [Full Text]  
  • Chahwan, C., Nakamura, T. M., Sivakumar, S., Russell, P., Rhind, N. (2003). The Fission Yeast Rad32 (Mre11)-Rad50-Nbs1 Complex Is Required for the S-Phase DNA Damage Checkpoint. Mol. Cell. Biol. 23: 6564-6573 [Abstract] [Full Text]  
  • Wang, X., Khadpe, J., Hu, B., Iliakis, G., Wang, Y. (2003). An Overactivated ATR/CHK1 Pathway Is Responsible for the Prolonged G2 Accumulation in Irradiated AT Cells. J. Biol. Chem. 278: 30869-30874 [Abstract] [Full Text]  
  • Orban, T I, Olah, E (2003). Emerging roles of BRCA1 alternative splicing. Mol. Pathol. 56: 191-197 [Abstract] [Full Text]  
  • Yamane, K., Chen, J., Kinsella, T. J. (2003). Both DNA Topoisomerase II-binding Protein 1 and BRCA1 Regulate the G2-M Cell Cycle Checkpoint. Cancer Res. 63: 3049-3053 [Abstract] [Full Text]  
  • Wu, G., Jiang, X., Lee, W.-H., Chen, P.-L. (2003). Assembly of Functional ALT-associated Promyelocytic Leukemia Bodies Requires Nijmegen Breakage Syndrome 1. Cancer Res. 63: 2589-2595 [Abstract] [Full Text]  
  • Gatei, M., Sloper, K., Sorensen, C., Syljuasen, R., Falck, J., Hobson, K., Savage, K., Lukas, J., Zhou, B.-B., Bartek, J., Khanna, K. K. (2003). Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent Phosphorylation of Chk1 on Ser-317 in Response to Ionizing Radiation. J. Biol. Chem. 278: 14806-14811 [Abstract] [Full Text]  
  • Morales, J. C., Xia, Z., Lu, T., Aldrich, M. B., Wang, B., Rosales, C., Kellems, R. E., Hittelman, W. N., Elledge, S. J., Carpenter, P. B. (2003). Role for the BRCA1 C-terminal Repeats (BRCT) Protein 53BP1 in Maintaining Genomic Stability. J. Biol. Chem. 278: 14971-14977 [Abstract] [Full Text]  
  • Lou, Z., Chini, C. C. S., Minter-Dykhouse, K., Chen, J. (2003). Mediator of DNA Damage Checkpoint Protein 1 Regulates BRCA1 Localization and Phosphorylation in DNA Damage Checkpoint Control. J. Biol. Chem. 278: 13599-13602 [Abstract] [Full Text]  
  • Kozlov, S., Gueven, N., Keating, K., Ramsay, J., Lavin, M. F. (2003). ATP Activates Ataxia-Telangiectasia Mutated (ATM) in Vitro. IMPORTANCE OF AUTOPHOSPHORYLATION. J. Biol. Chem. 278: 9309-9317 [Abstract] [Full Text]  
  • Xu, X., Stern, D. F. (2003). NFBD1/KIAA0170 Is a Chromatin-associated Protein Involved in DNA Damage Signaling Pathways. J. Biol. Chem. 278: 8795-8803 [Abstract] [Full Text]  
  • Shang, Y. L., Bodero, A. J., Chen, P.-L. (2003). NFBD1, a Novel Nuclear Protein with Signature Motifs of FHA and BRCT, and an Internal 41-Amino Acid Repeat Sequence, Is an Early Participant in DNA Damage Response. J. Biol. Chem. 278: 6323-6329 [Abstract] [Full Text]  
  • Weiss, R. S., Leder, P., Vaziri, C. (2003). Critical Role for Mouse Hus1 in an S-Phase DNA Damage Cell Cycle Checkpoint. Mol. Cell. Biol. 23: 791-803 [Abstract] [Full Text]  
  • Okada, S., Ouchi, T. (2003). Cell Cycle Differences in DNA Damage-induced BRCA1 Phosphorylation Affect Its Subcellular Localization. J. Biol. Chem. 278: 2015-2020 [Abstract] [Full Text]  
  • Donahue, S. L., Campbell, C. (2002). A DNA Double Strand Break Repair Defect in Fanconi Anemia Fibroblasts. J. Biol. Chem. 277: 46243-46247 [Abstract] [Full Text]  
  • Liu, Y., Virshup, D. M., White, R. L., Hsu, L.-C. (2002). Regulation of BRCA1 Phosphorylation by Interaction with Protein Phosphatase 1{alpha}. Cancer Res. 62: 6357-6361 [Abstract] [Full Text]  
  • Zhao, H., Watkins, J. L., Piwnica-Worms, H. (2002). Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints. Proc. Natl. Acad. Sci. USA 99: 14795-14800 [Abstract] [Full Text]  
  • Wang, X., Li, G. C., Iliakis, G., Wang, Y. (2002). Ku Affects the CHK1-dependent G2 Checkpoint after Ionizing Radiation. Cancer Res. 62: 6031-6034 [Abstract] [Full Text]  
  • Pichierri, P., Averbeck, D., Rosselli, F. (2002). DNA cross-link-dependent RAD50/MRE11/NBS1 subnuclear assembly requires the Fanconi anemia C protein. Hum Mol Genet 11: 2531-2546 [Abstract] [Full Text]  
  • Deming, P. B., Flores, K. G., Downes, C. S., Paules, R. S., Kaufmann, W. K. (2002). ATR Enforces the Topoisomerase II-dependent G2 Checkpoint through Inhibition of Plk1 Kinase. J. Biol. Chem. 277: 36832-36838 [Abstract] [Full Text]  
  • Taniguchi, T., Garcia-Higuera, I., Andreassen, P. R., Gregory, R. C., Grompe, M., D'Andrea, A. D. (2002). S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 100: 2414-2420 [Abstract] [Full Text]  
  • Beamish, H., Kedar, P., Kaneko, H., Chen, P., Fukao, T., Peng, C., Beresten, S., Gueven, N., Purdie, D., Lees-Miller, S., Ellis, N., Kondo, N., Lavin, M. F. (2002). Functional Link between BLM Defective in Bloom's Syndrome and the Ataxia-telangiectasia-mutated Protein, ATM. J. Biol. Chem. 277: 30515-30523 [Abstract] [Full Text]  
  • Xu, B., O'Donnell, A. H., Kim, S.-T., Kastan, M. B. (2002). Phosphorylation of Serine 1387 in Brca1 Is Specifically Required for the Atm-mediated S-Phase Checkpoint after Ionizing Irradiation. Cancer Res. 62: 4588-4591 [Abstract] [Full Text]  
  • Wang, H., Wang, X., Zhou, X.-Y., Chen, D. J., Li, G. C., Iliakis, G., Wang, Y. (2002). Ku Affects the Ataxia and Rad 3-related/CHK1-dependent S Phase Checkpoint Response after Camptothecin Treatment. Cancer Res. 62: 2483-2487 [Abstract] [Full Text]  
  • Zhou, X.-Y., Wang, X., Hu, B., Guan, J., Iliakis, G., Wang, Y. (2002). An ATM-independent S-Phase Checkpoint Response Involves CHK1 Pathway. Cancer Res. 62: 1598-1603 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, B.
Right arrow Articles by Kastan, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, B.
Right arrow Articles by Kastan, M. B.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»